elements
-live
Search elements, keywords, and sectors
🔎
Elements
Subjects
Papers
Communities
Lab
API & MCP
Pricing
Log in
Sign up
Home
/
Subjects
/
HEK 293 cells
← Back to subjects
Current data, viewed at
Yearly
resolution.
Personal members see monthly resolution →
Keyword
keyword
HEK 293 cells
RIS
0.002
(Research Intensity Score)
Papers
153
Top papers
Antimicrobial, antioxidant, and cytotoxic properties of biosynthesized copper oxide nanoparticles (CuO-NPs) using Athrixia phylicoides DC
2023 · 96 citations
Synthetic multistability in mammalian cells
2022 · 140 citations
The proton channel OTOP1 is a sensor for the taste of ammonium chloride
2023 · 50 citations
Nanotoxic Effects of Silver Nanoparticles on Normal HEK-293 Cells in Comparison to Cancerous HeLa Cell Line
2021 · 125 citations
Inhibition of tau neuronal internalization using anti-tau single domain antibodies
2025 · 19 citations
Newest papers
NLRP3 acts as a direct sensor of intracellular potassium ions
2026 · 2 citations
Enzyme-Responsive Chemiluminescent Probes Assembled with Iridium(III) Photosensitizers via Host–Guest Chemistry for Chemiluminescence-Induced Photodynamic Therapy
2026 · 1 citations
PCB 153 Modulates Genes Involved in Proteasome and Neurodegeneration-Related Pathways in Differentiated SH-SY5Y Cells: A Transcriptomic Study
2026 · 2 citations
Gold Nanorod-Affibody Conjugates Mediate Cancer Photothermal Therapy under 808 nm LED Irradiation
2026 · 1 citations
Extracellular vesicle-associated α-synuclein disrupts retrograde signalling-endosome trafficking in recipient neurons
2026
A sample from the 100 top papers behind HEK 293 cells.
Create a free account to browse them all →
HEK 293 cells's history
Research intensity over time
Explore HEK 293 cells's full history
Hover any year for its value and switch resolutions with a free account. Personal adds monthly detail and the historical-intensity (HRI) line.
Create a free account
Already have an account?
Log in
to explore the data.
Close ✕
HEK 293 cells's papers
Ordered by current research-activity contribution.
Loading…
Close ✕
Read full text ↗
Share
Share on X
Share on Facebook
Share on LinkedIn
Copy link